July 24, 2016
Recommended Topic Related To:

Trokendi XR

"A relatively new once-a-day antiepileptic drug (AED) is as effective as an older standard one given twice daily, according to a randomized trial.

Results of the blinded phase 3 study showed eslicarbazepine acetate to be noninferior to"...


Trokendi XR

(topiramate) Extended-release Capsules


Topiramate, USP, is a sulfamate-substituted monosaccharide. TROKENDI XR® (topiramate) extended-release capsules are available as 25 mg, 50 mg, 100 mg and 200 mg capsules for oral administration.

Topiramate is a white to off-white powder. Topiramate is freely soluble in polar organic solvents such as acetonitrile and acetone; and very slightly soluble to practically insoluble in non-polar organic solvents such as hexanes. Topiramate has the molecular formula C12H21NO8S and a molecular weight of 339.4. Topiramate is designated chemically as 2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamate and has the following structural formula:

TROKENDI XR (topiramate) Structural Formula Illustration

TROKENDI XR® (topiramate) is an extended-release capsule. TROKENDI XR® capsules contain the following inactive ingredients:

Sugar Spheres, NF
Hypromellose (Type 2910), USP
Mannitol, USP
Docusate Sodium, USP
Sodium Benzoate, NF
Ethylcellulose, NF
Oleic Acid, NF
Medium Chain Triglycerides, NF
Polyethylene Glycol, NF
Polyvinyl Alcohol, USP
Titanium Dioxide, USP
Talc, USP
Lecithin, NF
Xanthan Gum, NF

The capsule shells contain gelatin, USP; Titanium Dioxide, USP; and Colorants.

The colorants are:

FD&C Blue #1 (all strength capsules)
Yellow Iron Oxide, USP (25 mg and 50 mg capsules)
FD&C Red #3 (50 mg, 100 mg and 200 mg capsules)
FD&C Yellow #6 (50 mg, 100 mg and 200 mg capsules)
Riboflavin, USP (25 mg capsules)

All capsule shells are imprinted with black print that contains shellac, NF, and black iron oxide, NF.

Last reviewed on RxList: 9/2/2015
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Find tips and treatments to control seizures.